Abdi Seifollah, Baianati Mohammad Reza, Momtahen Mahmood, Mohebbi Bahram
Cardiovascular Intervention Research Center, Rajaie Cardiovascular, Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran.
Madaen Hospital, Tehran, Iran.
J Tehran Heart Cent. 2019 Jul;14(3):138-140.
Intramural esophageal dissection is a condition that typically presents with chest pains and may be associated with hematemesis, odynophagia, and hematemesis. The role of antiplatelet/anticoagulant agents in the development of intramural esophageal hematoma is controversial. The management of intramural esophageal dissection is generally conservative with low mortality and morbidity. The case described here is a 66-year-old woman who presented with chest pains, odynophagia, and dysphagia 1 month after percutaneous coronary intervention while taking ASA (80 mg daily) and clopidogrel (75 mg daily) for dual antiplatelet therapy. The patient was diagnosed as intramural esophageal dissection and underwent successful conservative medical management. The relative contribution of dual antiplatelet therapy with ASA and clopidogrel after percutaneous coronary intervention in this case is, albeit uncertain, a possibility.
壁内食管夹层是一种通常表现为胸痛的病症，可能伴有呕血、吞咽痛和咯血。抗血小板/抗凝剂在壁内食管血肿形成中的作用存在争议。壁内食管夹层的治疗通常是保守的，死亡率和发病率较低。此处描述的病例是一名66岁女性，在接受经皮冠状动脉介入治疗1个月后出现胸痛、吞咽痛和吞咽困难，当时正在服用阿司匹林（每日80毫克）和氯吡格雷（每日75毫克）进行双重抗血小板治疗。该患者被诊断为壁内食管夹层，并成功接受了保守药物治疗。在这种情况下，经皮冠状动脉介入治疗后使用阿司匹林和氯吡格雷进行双重抗血小板治疗的相对作用虽然不确定，但却是一种可能。
